Covered recipient · General Payments record
LARA T DUDEK
Allopathic & Osteopathic Physicians Ophthalmology
General Payments · PY2018–2024
$5,159.85
- Reported across 120 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,080.35 | 28 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $273.03 | 8 |
| RxSight Inc | $242.79 | 9 |
| GLAUKOS CORPORATION | $186.27 | 2 |
| Bausch & Lomb Americas Inc. | $156.52 | 4 |
| Apellis Pharmaceuticals, Inc. | $121.52 | 1 |
| Ocular Therapeutix, Inc. | $76.46 | 3 |
| BIOTISSUE HOLDINGS INC. | $23.76 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (28)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $27.78 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103663654 | CMS |
| ABBVIE INC. | $20.32 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103663656 | CMS |
| ABBVIE INC. | $104.21 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103663658 | CMS |
| ABBVIE INC. | $27.72 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103663660 | CMS |
| ABBVIE INC. | $28.68 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103663662 | CMS |
| ABBVIE INC. | $25.29 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103663664 | CMS |
| ABBVIE INC. | $22.03 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103663666 | CMS |
| ABBVIE INC. | $17.00 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103663668 | CMS |
| Apellis Pharmaceuticals, Inc. | $121.52 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154024789 | CMS |
| Bausch & Lomb Americas Inc. | $94.37 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140391998 | CMS |
| Bausch & Lomb Americas Inc. | $16.24 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140391992 | CMS |
| Bausch & Lomb Americas Inc. | $23.55 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140391996 | CMS |
| Bausch & Lomb Americas Inc. | $22.36 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140391994 | CMS |
| BIOTISSUE HOLDINGS INC. | $23.76 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148784799 | CMS |
| Glaukos Corporation | $165.84 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151994446 | CMS |
| Glaukos Corporation | $20.43 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151989124 | CMS |
| Ocular Therapeutix, Inc. | $27.68 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148200737 | CMS |
| Ocular Therapeutix, Inc. | $20.88 | 05/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148200739 | CMS |
| Ocular Therapeutix, Inc. | $27.90 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148200741 | CMS |
| RxSight Inc | $58.56 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144215829 | CMS |
| RxSight Inc | $32.88 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144215831 | CMS |
| RxSight Inc | $17.93 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144215833 | CMS |
| RxSight Inc | $23.09 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144215835 | CMS |
| RxSight Inc | $44.27 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144215837 | CMS |
| RxSight Inc | $24.06 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144215839 | CMS |
| RxSight Inc | $12.45 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144215841 | CMS |
| RxSight Inc | $9.96 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144215843 | CMS |
| RxSight Inc | $19.59 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144215845 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.